News in the Life Sciences Industry

- Quizartinib is the first FLT3 inhibitor to demonstrate a survival benefit in a randomized phase 3 study in patients with FLT3-ITD AML, which was refractory or relapsed within six months of first remission, a very aggressive subtype of the disease associated with poor prognosis

Deepening commitment to drive improvements for patients with respiratory disease across Asia, AstraZeneca with Business Sweden, The Swedish Trade & Invest Council in Taiwan, hosts the second Healthy Lung Summit, ahead of the 2018 Asia Pacific Society of Respirology Meeting

AACHEN, Germany, December 3, 2018 /PRNewswire/ --

-- Grants Program Supports Projects that Engage Young Adults and Communities Affected by HIV/AIDS --

SHANGHAI, Nov. 30, 2018 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, today opened its first Bioprocess Design Center in Shanghai, China. The new center is part of a strategy to establish a center of excellence where Thermo Fisher scientists can connect and collaborate... Read more ››

BRUSSELS and ATLANTA, Nov. 30, 2018 /PRNewswire/ -- UCB is excited to be presenting 20 abstracts at this year's American Epilepsy Society Meeting, taking place between November 30 and December 4 in New Orleans, Louisiana.

- Global collaboration will initially evaluate Innovent's anti-PD-1 monoclonal antibody sintilimab in combination with Hutchison MediPharma's VEGFR inhibitor fruquintinib for solid tumors -

LONDON, November 28, 2018 /PRNewswire/ --

SINGAPORE, Nov. 28, 2018 /PRNewswire/ -- At the Ministerial Roundtable held on the second day of the Ministerial Conference on Diabetes, the Health Ministers and senior government representatives affirmed their commitment to enhance innovation and strengthen international partnerships and collaborations... Read more ››

TUCSON, Ariz., Nov. 27, 2018 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global launch of the VENTANA pan-TRK (EPR17341) Assay, the first automated in vitro diagnostic (IVD) immunohistochemistry (IHC) assay to detect tropomyosin receptor kinase (TRK) proteins in cancer.... Read more ››

DARMSTADT, Germany, Nov. 27, 2018 /PRNewswire/ -- Merck, a leading science and technology company, today announced that it has won two R&D... Read more ››

INGELHEIM, Germany and INDIANAPOLIS, Ind., Nov. 27, 2018 /PRNewswire/ -- A new Expert Consensus Decision Pathway issued by the American College of Cardiology (ACC) recommends empagliflozin as the preferred SGLT2 inhibitor for its proven benefit in reducing the risk of cardiovascular death in... Read more ››

TORONTO, November 26, 2018 /PRNewswire/ --

TOKYO, November 26, 2018 /PRNewswire/ --

CHICAGO and NUREMBERG, Germany, Nov. 25, 2018 /PRNewswire/ -- At this year's RSNA in Chicago, Ziehm Imaging underlines its strong commitment to set new technology standards. The innovation leader in mobile X-ray imaging showcases a broad variety of C-arms to provide suitable options for surgeons'... Read more ››